E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers A > Headlines for Aurobindo Pharma Ltd. > News item
Published on 1/16/2009 in the Prospect News Convertibles Daily.

Aurobindo Pharma repurchases $8.3 million in 0% convertibles

By Devika Patel

Knoxville, Tenn., Jan. 16 - Aurobindo Pharma Ltd. informed the Singapore Stock Exchange that it will buy back and cancel $8.3 million of it $150 million in zero-coupon convertible bonds due 2011.

Aurobindo is a pharmaceutical company located in Hyderabad, India.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.